(Total Views: 89)
Posted On: 04/18/2024 9:55:48 AM
Post# of 63
$BPTH News Article - Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients https://marketwirenews.com/news-releases/bio-...70003.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
